Markus Kreuz

18.4k citations

50 papers · 1.0k indexed · 1 hit paper · h-index 19

Impact in

Pathology and Forensic Medicine top 2%
- Lymphoma Diagnosis and Treatment
- Cancer Mechanisms and Therapy
Genetics top 5%
- Chronic Lymphocytic Leukemia Research

Papers in

Pathology and Forensic Medicine 20
- Lymphoma Diagnosis and Treatment 19
Genetics 10
- Chronic Lymphocytic Leukemia Research 8

Co-authors: Inga Vater Lorenz Trümper Reiner Siebert Markus Loeffler Stefan Gesk Wolfram Klapper Michael Pfreundschuh Martin Hasselblatt
Journals: British Journal of Haematology (3 papers)Cancers (3 papers)Blood (3 papers)Leukemia (2 papers)JDDG Journal der Deutschen Dermatologischen Gesellschaft (2 papers)
Partner nations: Germany Switzerland United States

In The Last Decade

Markus Kreuz

41 papers receiving 1.0k citations

Hit Papers

align trajectories log scale

Statin use and dementia risk: A systematic review and updated meta‐analysis 2025 · 14 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2025 Alzheimer s & Dementia Translational Research & Clinical Interventions

Peers

Countries citing papers authored by Markus Kreuz

Since Specialization

Citations

This map shows the geographic impact of Markus Kreuz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Kreuz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Kreuz more than expected).

Fields of papers citing papers by Markus Kreuz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Kreuz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Kreuz. The network helps show where Markus Kreuz may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Kreuz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Kreuz Line = papers co-authored together Markus Kreuz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Age‐ and gender‐specific molecular characteristics of diffuse large B‐cell lymphoma: Results from clinical trials of the DSHNHL/GLA HemaSphere ·Katrin S. Kurz, C. Nicolle, Markus Kreuz, Marita Ziepert, Annette M. Staiger, Thomas F.E. Barth, Peter Mӧller, Heinz‐Wolfram Bernd, Alfred C. Feller, Julia Richter, Wolfram Klapper, Harald Stein, Sylvia Hartmann, Martin‐Leo Hansmann, Lorenz Trümper, Markus Loeffler, Norbert Schmitz, Andreas Rosenwald, German Ott, Heike Horn, (unknown)	2025	0
2	Statin use and dementia risk: A systematic review and updated meta‐analysis Alzheimer s & Dementia Translational Research & Clinical Interventions ·Yuya Suzuki, K. Józefowicz, leaburto, Т.Е. Самсонов, M. Trias, Cao Feng-chun, Francisco Cézar Aquino de Moraes, Markus Kreuz, Tillmann Blume, S. L. Wagaarachchi Hit paper breakdown →	2025	14
3	Immune cells play a critical role in cytokine- and endotoxin-mediated endothelial permeability PLoS ONE ·Patricia Gogesch, Nurani, BL Broadhead, Joachim Rom, Markus Kreuz, Kristin Reiche, Martina Anzaghe, Zoe Waibler	2025	0
4	Predicting progression events in multiple myeloma from routine blood work npj Digital Medicine ·D EDWARDS, 有紀子岳川, Markus Kreuz, N. Elahi, Hartmut Goldschmidt, А. А. Пичугина, 宏山中, Uwe Platzbecker, Thomas Neumuth, Kristin Reiche, Louis A. Merillat, Maximilian Merz	2025	1
5	Virtual twins for personalised CAR T-cell therapy in myeloma The Lancet Haematology ·Kristin Reiche, Ulrike Weirauch, Markus Kreuz, Luise Fischer, Jean Zagdoun, Thomas Neumuth, Uwe Platzbecker, Ulrike Koehl, Regina Demlová, Andreas Kremer, Holger Fröhlich, Stefan Franke, Maximilian Merz, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2025	0
6	Treatment With PD-1/PD-L1 Inhibitors for Kaposi Sarcoma:A Systematic Review and Meta-Analysis Journal of Immunotherapy ·Francisco Cézar Aquino de Moraes, Markus Kreuz, P. Wagner, MAURICE R. PUYAU, S.-E. Zhang, Florian Schaffenrath, 小林圭太, 반현정, Rommel Mário Rodríguez Burbano	2025	0
7	Predicting Progression Events in Multiple Myeloma from Routine Blood Work Blood ·Runlong Ye, 有紀子岳川, Markus Kreuz, Uwe Platzbecker, Thomas Neumuth, Kristin Reiche, Louis A. Merillat, Maximilian Merz	2024	0
8	Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancer BMC Cancer ·正弘福原, MarcusOlivecrona, S. Füssel, Dennis Löffler, Conny Blumert, Catharina Bertram, Angelika Borkowetz, Victoria Silvia Sánchez, Sven-Holger Puppel, Pia Hönscheid, Ulrich Sommer, Gustavo Baretton, Ulrike Köhl, Manfred P. Wirth, Christian Thomas, Friedemann Horn, Markus Kreuz, Kristin Reiche	2023	2
9	Classifying Germinal Center Derived Lymphomas—Navigate a Complex Transcriptional Landscape Cancers ·Henry Loeffler‐Wirth, Markus Kreuz, Jvana Abi, German Ott, Reiner Siebert, Hans Binder	2022	10
10	Transcriptional states of CAR-T infusion relate to neurotoxicity – lessons from high-resolution single-cell SOM expression portraying Frontiers in Immunology ·Henry Loeffler‐Wirth, MarcusOlivecrona, Arsen Arakelyan, Markus Kreuz, Markus Loeffler, Ulrike Koehl, Kristin Reiche, Hans Binder	2022	5
11	Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2 Haematologica ·Heike Horn, Christian Köhler, CARLOS EVANDRO BRITO PEREIRA DE MENESES, Markus Kreuz, Ellen Leich, Wolfram Klapper, Michael Hummel, Markus Loeffler, Lorenz Trümper, Rainer Spang, Andreas Rosenwald, German Ott, (unknown)	2018	29
12	Stress-related hormones in association with periodontal condition in adolescents—results of the epidemiologic LIFE Child study Clinical Oral Investigations ·Jana Schmidt, Qasim Saeed, Markus Kreuz, Markus Löffler, Wieland Kieß, Christian Hirsch, Joachim Thiery, Ronny Baber, Yoon Ju Bae, Jürgen Kratzsch, Rainer Haak, Dirk Ziebolz	2018	3
13	Genomic and epigenomic co-evolution in follicular lymphomas Leukemia ·Markus Loeffler, Markus Kreuz, Andrea Haake, Dirk Hasenclever, Heiko Trautmann, Christian Arnold, Karsten Winter, Karoline Koch, Wolfram Klapper, 守羽成, Maciej Rosołowski, Steve Hoffmann, Ole Ammerpohl, Monika Szczepanowski, D. Herrmann, Ralf Küppers, Christiane Pott, Reiner Siebert, (unknown)	2014	42
14	Circulating Levels of TNF Receptor II Are Prognostic for Patients with Peripheral T-cell Non–Hodgkin Lymphoma Clinical Cancer Research ·Waheed Ahmad Qureshi, Markus Kreuz, І. PRYDATKO, Nils Schoof, Frederike von Bonin, Marita Ziepert, Markus Löffler, Wolfram Jung, Michael Pfreundschuh, Lorenz Trümper, Dieter Kube	2012	32
15	Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition Syndrome The American Journal of Human Genetics ·Reinhard Schneppenheim, Michael C. Frühwald, Stefan Gesk, Martin Hasselblatt, Astrid Jeibmann, Uwe Kordes, Markus Kreuz, Ivo Leuschner, Masami Machida, Tobias Obser, Florian Oyen, Inga Vater, Reiner Siebert	2010	222
16	A Functional Polymorphism in the NAD(P)H Oxidase Subunit CYBA Is Related to Gene Expression, Enzyme Activity, and Outcome in Non–Hodgkin Lymphoma Cancer Research ·Marion Hoffmann, Markus Schirmer, Mladen V. Tzvetkov, Markus Kreuz, Marita Ziepert, Leszek Wojnowski, Dieter Kube, Michael Pfreundschuh, Lorenz Trümper, Markus Loeffler, Jürgen Brockmöller	2010	21
17	Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis Haematologica ·守羽成, Markus Kreuz, Wolfram Klapper, Wathsala Abeykoon, A.C. Feller, Michael Hummel, Markus Loeffler, Maciej Rosołowski, Carsten Schwäenen, Rainer Spang, Harald Stein, Christoph Thorns, Lorenz Trümper, Inga Vater, Swen Weßendorf, Thorsten Zenz, Reiner Siebert, Ralf Küppers, (unknown)	2010	41
18	GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma British Journal of Haematology ·Inga Vater, Florian Wagner, Markus Kreuz, Hilmar Berger, José I. Martı́n-Subero, Christiane Pott, José A. Martínez-Climent, Wolfram Klapper, Kristina Krause, Martin J.S. Dyer, Stefan Gesk, Lana Harder, Alberto Zamò, Martin Dreyling, Dirk Hasenclever, Norbert Arnold, Reiner Siebert	2008	22
19	MDM2 gene SNP309 T/G and p53gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians BMC Cancer ·Joerg Thomas Bittenbring, Estefania C. Ruano Herreria, Eduardo R. Ferreira, A. Schoenmakers, C Nieves Atrio Mouriño, Markus Kreuz, Lorenz Truemper, Olfert Landt, Alain Menzel, Michael Pfreundschuh, Klaus Roemer	2008	20
20	Development and Implementation of an Analysis Tool for Array-based Comparative Genomic Hybridization Methods of Information in Medicine ·박두환, Hilmar Berger, Carsten Schwäenen, David Chodura, Markus Loeffler, Marcella M. McCormack, Markus Kreuz	2007	8

About Markus Kreuz

Markus Kreuz is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Cancer Research and Otorhinolaryngology, having authored 50 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (19 papers), Viral-associated cancers and disorders (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Cancer Genomics and Diagnostics (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), CAR-T cell therapy research (4 papers), T-cell and B-cell Immunology (4 papers) and Single-cell and spatial transcriptomics (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (601 citations), Genetics (210 citations), Oncology (392 citations), Neurology (134 citations) and Immunology (180 citations). Markus Kreuz has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Inga Vater, Lorenz Trümper, Reiner Siebert, Markus Loeffler, Stefan Gesk, Wolfram Klapper, Reiner Siebert, Michael Pfreundschuh, Martin Hasselblatt and Uwe Kordes. Their work appears in journals such as British Journal of Haematology, Cancers, Blood, Leukemia and JDDG Journal der Deutschen Dermatologischen Gesellschaft.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact